Greenwich LifeSciences, Inc. - Common stock (GLSI)
GLSI moved a median of +0.44% 30 minutes after news, and -0.23% by the close. How GLSI actually reacts to news — the realized, point-in-time move the market made, measured across 153 labeled events over the last three years with zero look-ahead.
GLSI’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 49% | 144 |
| 30-min | +0.44% | 60% | 151 |
| 60-min | +0.16% | 51% | 153 |
| to close | -0.23% | 48% | 151 |
| Middle 50% of GLSI reactions | -1.02% to +1.43% |
|---|---|
| Median reaction (30-min) | +0.44% |
| Measured reactions | 153 |
Half of all Greenwich LifeSciences, Inc. - Common stock news events land between -1.02% and +1.43% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when GLSI moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to GLSI's baseline. Nothing else.
Recent GLSI events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 10-Q Greenwich LifeSciences, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.06% | +6.75% | |
| Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027 | Press release | GlobeNewswire | +2.27% | — | |
| Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom | Press release | GlobeNewswire | +2.57% | -7.72% | |
| Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01 | Press release | GlobeNewswire | +2.26% | -14.10% | |
| Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01 | Press release | GlobeNewswire | +1.39% | -5.80% | |
| Greenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01 | Press release | GlobeNewswire | +1.10% | -2.30% | |
| Form 10-Q Greenwich LifeSciences, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +2.24% | +0.21% | |
| Form 10-K Greenwich LifeSciences, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -5.00% | -10.07% | |
| Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026 | Press release | GlobeNewswire | +1.44% | +5.09% | |
| Greenwich LifeSciences Provides Update Regarding Form 10-K Filing | Press release | GlobeNewswire | +1.44% | +5.09% | |
| Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing | Press release | GlobeNewswire | +0.21% | -1.65% | |
| Greenwich LifeSciences Provides Update Regarding Form 10-K Filing | Press release | GlobeNewswire | +0.99% | +9.30% | |
| Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026 | Press release | GlobeNewswire | +0.68% | -2.99% | |
| Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing | Press release | GlobeNewswire | +0.68% | -2.99% | |
| Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026 | Press release | GlobeNewswire | +1.08% | -11.80% | |
| Greenwich LifeSciences Provides Update on Financing Strategy | Press release | GlobeNewswire | +1.13% | -5.35% | |
| Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential | Press release | GlobeNewswire | -2.90% | +0.49% | |
| Form NT 10-K Greenwich LifeSciences, For: Dec 31 | SEC filing · Form NT | SEC EDGAR | +2.81% | -3.69% | |
| Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01 | Press release | GlobeNewswire | -0.93% | +0.47% | |
| Greenwich LifeSciences Provides Update on Upcoming AACR Meeting | Press release | GlobeNewswire | -0.38% | -8.37% | |
| Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01 | Press release | GlobeNewswire | -1.60% | +10.72% | |
| Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01 | Press release | GlobeNewswire | -1.78% | +0.11% | |
| Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01 | Press release | GlobeNewswire | +2.02% | +3.85% | |
| Greenwich LifeSciences Announces Acceptance of Two Abstracts at AACR Annual Meeting 2026 | Press release | GlobeNewswire | +1.00% | +8.17% | |
| $170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium | Press release | PR Newswire | +0.40% | +6.30% | |
| Greenwich LifeSciences Provides Update on FLAMINGO-01 Cash Burn Rate and Financing Strategy | Press release | GlobeNewswire | +3.59% | +13.70% | |
| Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01 | Press release | GlobeNewswire | +5.92% | -13.35% | |
| Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026 | Press release | GlobeNewswire | -1.37% | +16.94% | |
| Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy | Press release | GlobeNewswire | +1.51% | +0.04% | |
| Form 8-K Greenwich LifeSciences, For: Dec 18 | SEC filing · Form 8-K | SEC EDGAR | +0.41% | +6.99% | |
| Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01 | Press release | GlobeNewswire | +2.37% | -20.69% | |
| Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01 | Press release | GlobeNewswire | +1.89% | +4.23% | |
| Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date | Press release | GlobeNewswire | +6.39% | +4.34% | |
| Form 10-Q Greenwich LifeSciences, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.71% | -1.91% | |
| Form ARS Greenwich LifeSciences, For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.80% | -7.12% | |
| Form DEF 14A Greenwich LifeSciences, For: Nov 03 | SEC filing · Form DEF | SEC EDGAR | +0.80% | -7.12% | |
| Form DEFA14A Greenwich LifeSciences, | SEC filing · Form DEFA14A | SEC EDGAR | +0.80% | -7.12% | |
| Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial | Press release | GlobeNewswire | +0.00% | -1.58% | |
| Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium | Press release | GlobeNewswire | +0.55% | +6.29% | |
| Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial | Press release | GlobeNewswire | +5.28% | -0.90% | |
| Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland | Press release | GlobeNewswire | +0.39% | +0.96% | |
| Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation | Press release | GlobeNewswire | -2.69% | -12.38% | |
| Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences | Press release | GlobeNewswire | -2.17% | -0.33% | |
| Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team | Press release | GlobeNewswire | +0.86% | — | |
| Form 10-Q Greenwich LifeSciences, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -0.25% | |
| Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania | Press release | GlobeNewswire | +0.00% | -5.76% | |
| Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events | Press release | GlobeNewswire | +0.65% | +1.22% | |
| Form 8-K Greenwich LifeSciences, For: Jul 19 | SEC filing · Form 8-K | SEC EDGAR | -2.44% | +0.70% | |
| Greenwich LifeSciences Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV | Press release | ACCESS Newswire | +0.00% | -0.11% | |
| Form 10-Q Greenwich LifeSciences, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +2.86% | -2.70% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the GLSI section they belong to.
Where else GLSI is measured.
GLSI earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Greenwich LifeSciences, Inc. - Common stock's median reaction calculated?
Every labeled GLSI news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 153 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 60% of GLSI's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does GLSI's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.